Heartflow (HTFL) Return on Capital Employed (2025)

Heartflow's (HTFL) quarterly Return on Capital Employed came in at 19.6% in Q4 2025, up 26.59% quarter-over-quarter from 26.69% in Q3 2025.

Heartflow (HTFL) Return on Capital Employed (2025) Analysis & Trends

Heartflow's Return on Capital Employed history runs 1 years deep, the most recent figure standing at 19.6% for Q4 2025.

On a quarterly basis, Return on Capital Employed changed N/A year-over-year to 19.6% in Q4 2025; TTM through Dec 2025 was 19.6%, a N/A change from a year earlier, with the FY2025 full-year figure at 32.57%, changed N/A from the prior year.
Return on Capital Employed rose to 19.6% in Q4 2025 per HTFL's latest filing, from 26.69% in the prior quarter.
Across five years, Return on Capital Employed topped out at 19.6% in Q4 2025 and bottomed at 55.5% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Veeva Systems	29.34 Bn	22.03 Bn	662.02 Mn	13.00%
2	BrightSpring Health Services	13.49 Bn	12.59 Bn	482.22 Mn	7.68%
3	Healthequity	7.96 Bn	7.70 Bn	256.31 Mn	10.67%
4	10x Genomics	6.17 Bn	5.63 Bn	106.18 Mn	-4.23%
5	Hinge Health	6.02 Bn	5.70 Bn	154.23 Mn	-163.65%
6	MiniMed	4.19 Bn	3.89 Bn	480.00 Mn	-8.46%
7	Waystar Holding	4.14 Bn	4.07 Bn	216.84 Mn	4.73%
8	Doximity	3.82 Bn	3.08 Bn	125.97 Mn	21.81%
9	Privia Health	3.10 Bn	2.73 Bn	-	4.60%
10	Heartflow	906.97 Mn	730.19 Mn	39.06 Mn	-19.60%

Download Data